Why is it so quiet? Do the vast majority really believe that when they say "no restructure going into the beginning of next year" they mean we are good at least for another year? After all, didn't they word it kind of like that last year? People thought we were good and then we were hit in February. What on earth are they getting ready to pull this time? When was the last time they limited budgets? Managers talking (but sweating bullets at the same time) about our GREAT pipeline in the future? Maybe I am just tainted from the past, because Ive been through this ten times before with Sanofi, but I am not buying it. Just wondering what others are thinking.
Restructurings, realighments, right-sizing, reductions in force, and any other euphemism you care to throw at it will continue. It has become this way in pretty much all of the pharma industry and unless you work for a smaller company with an unpartnered, first-in-class drug that needs to be detailed, chances are a company will not be adding heads. Sanofi is definitely on the downward side of that hill. The honest answer that management can give is that headcount will track results. If there are a few quarters with weaker than expected earnings, that will immediately be followed by some more lay-offs. Very few jobs are safe in pharma these days; sales forces are downsized as more physician offices decline to allow salespeople through the front door, R&D projects are constantly trimmed as therapeutic areas are cut back in favor of targeted acquisitions, and manufacturing, especially of small molecule drugs, is increasingly being outsourced to contract manufacturers. Forget what management says they are or are not going to do. If Wall Street doesn't like the financial results then you should know what comes next and it is not just at Sanofi. That said, Sanofi has one of the weakest positions among the largish pharma companies and will take more hits than most.
Time to warm up the network. Found a pharma meeting in Boston on Oct 29 on eventbrite. Even got approval to expense it! Least they can do before phone calls and competing with my team.
Sorry to say but Bridgewater is under attack and will be sold. Moving to Cambridge 2019 will be a rummage sale.
It has been stated before we will continue to promote diabetes because it is funding re-.org. Bridgewater is already pretty vacant and Cambridge is the future. 2019 will have changed that effect all aspects of field sales and management.
https://www.bostonglobe.com/business/2018/10/15/sanofi-genyzme-looking-expand-cambridge/FXSUu6IPgQzPy7eAFXiJ4H/story.html
